ATE325109T1 - Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten - Google Patents

Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten

Info

Publication number
ATE325109T1
ATE325109T1 AT01272833T AT01272833T ATE325109T1 AT E325109 T1 ATE325109 T1 AT E325109T1 AT 01272833 T AT01272833 T AT 01272833T AT 01272833 T AT01272833 T AT 01272833T AT E325109 T1 ATE325109 T1 AT E325109T1
Authority
AT
Austria
Prior art keywords
benzofuran derivatives
pharmaceutical compositions
compositions containing
containing same
hydrogen atom
Prior art date
Application number
AT01272833T
Other languages
English (en)
Inventor
Nobuyuki Kawakatsu
Takayuki Namiki
Norihisa Yamazaki
Masayuki Yuasa
Toyohiko Miki
Noriko Suenobu
Tomomasa Shimanuki
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of ATE325109T1 publication Critical patent/ATE325109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01272833T 2000-12-27 2001-12-21 Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten ATE325109T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000398075 2000-12-27

Publications (1)

Publication Number Publication Date
ATE325109T1 true ATE325109T1 (de) 2006-06-15

Family

ID=18863108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01272833T ATE325109T1 (de) 2000-12-27 2001-12-21 Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten

Country Status (7)

Country Link
US (1) US6797711B2 (de)
EP (1) EP1346987B1 (de)
JP (1) JP3990632B2 (de)
AT (1) ATE325109T1 (de)
CA (1) CA2439730A1 (de)
DE (1) DE60119378T8 (de)
WO (1) WO2002053550A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186726B2 (en) * 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives
US20080139578A1 (en) * 2006-11-30 2008-06-12 Catherine Abbadie Substituted piperizines for the treatment of pain
JP5743137B2 (ja) * 2011-01-14 2015-07-01 ソニー株式会社 信号処理装置および方法、並びにプログラム
WO2016045587A1 (zh) * 2014-09-26 2016-03-31 常州寅盛药业有限公司 作为ns4b抑制剂的苯并呋喃类似物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10175965A (ja) * 1996-12-17 1998-06-30 Sumitomo Pharmaceut Co Ltd テトラヒドロベンズイソオキサゾール誘導体
JPH10175964A (ja) * 1996-12-18 1998-06-30 Sumitomo Pharmaceut Co Ltd アミノイソオキサゾール誘導体
JPH11106340A (ja) * 1997-10-02 1999-04-20 Sumitomo Pharmaceut Co Ltd Ｓｔａｔ６活性化阻害剤
JPH11116481A (ja) 1997-10-06 1999-04-27 Sumitomo Pharmaceut Co Ltd スタット６活性化阻害剤

Also Published As

Publication number Publication date
JPWO2002053550A1 (ja) 2004-05-13
EP1346987A4 (de) 2004-11-17
US6797711B2 (en) 2004-09-28
EP1346987B1 (de) 2006-05-03
DE60119378T8 (de) 2007-03-29
EP1346987A1 (de) 2003-09-24
JP3990632B2 (ja) 2007-10-17
DE60119378D1 (de) 2006-06-08
WO2002053550A1 (fr) 2002-07-11
US20040053940A1 (en) 2004-03-18
CA2439730A1 (en) 2002-07-11
DE60119378T2 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
ATE448199T1 (de) Verbindungen mit taxol-verstärkender wirkung
DE69415445D1 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
HUP0401889A2 (hu) 1,8-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
DE69736642D1 (de) Heterocyclische Verbindungen, ihre Herstellung und Verwendung
ATE294185T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediäre zur herstellung der derivate
IL140554A0 (en) Oxamyl derivatives and pharmaceutical compositions containing the same
DE69219221D1 (de) Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE3774795D1 (de) Phenoxyessigsaeure-verbindungen, ihre herstellung, pharmazeutische zusammensetzungen und deren verwendung.
ATE427944T1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
FI933681A0 (fi) Antimikrobiellt medel
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ATE325109T1 (de) Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten
ATE267191T1 (de) Tricyclische aminderivate
ATE420853T1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
FI941863A0 (fi) Oksatsolidonijohdannainen
KR880007070A (ko) 백내장 치료용 약학 조성물
ATE58129T1 (de) Dem antibiotikum tan-749 aehnliche verbindungen und ihre herstellung.
ATE278701T1 (de) Malto-oligosaccharide und deren verwendung
DE3787451D1 (de) Antibakterielles Mittel für Anwendung bei Säugetieren mit Cephalosporinverbindungen als effektiven Bestandteil.
DK0717990T3 (da) Præparat til behandling af lægemiddelafhængighed
DK460789D0 (da) 2-aminoacetamidderivater
TH61369A (th) สารผสมต้านแบคทีเรีย
DE69200900D1 (de) 1,5-Diyn-3-cycloalkenderivate, ihr Herstellungsverfahren und diese enthaltende pharmazeutische Compositionen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties